T1D Exchange Annual Meeting

T1D Exchange Annual Meeting 2017-09-20T15:29:14+00:00


8:00 – 8:20 am: Welcome and Overview

  • Dana Ball, Executive Director and Co-founder, T1D Exchange

8:20 – 9:00 am: Aging with T1D

Featuring a range of people living with type 1 diabetes will discuss a variety of topics, including health changes as one ages, the challenges, gaps and burden of living with the disease over a long duration, challenges with access to care and why patient-centered research is so important in today’s healthcare landscape


  • Dana Ball, Executive Director and Co-Founder, T1D Exchange


  • Nick Argento
  • Bunny Kasper
  • Sandy Brooks
  • Paul Madden

9:00 – 9:40 am: The Crucial Role of Patient Centered Research (PCR) in the Treatment of Type 1

Our expert panel will include a discussion about the role of PCR in identifying unmet patient needs and filling gaps in treatment and care to improve outcomes of people with T1D


  • Alicia McAuliffe-Fogarty, Vice President, Patient-Centered Research, T1D Exchange


  • Jeffrey Brewer, President & CEO, Bigfoot Biomedical
  • Anne Kirstine Busk, Global HEOR Lead, Novo Nordisk A/S
  • Magaly Perez-Nieves, MPH, PhD., Research Scientist, Eli Lilly
  • Soren E. Skovlund, MSc., Bsc, Dgr., Senior Researcher, Lead, Patient Reported Outcomes, Faculty of Health Sciences, Aalborg University, Denmark and Chief Patient Officer, DrugStars

9:40 – 10:00 am: BREAK

10:00 – 10:50 am: The T1D Exchange Clinic Registry – Recent Highlights, Data & Insights

A data-rich presentation on using patient reported outcomes to advance therapies using the CGM development as a model.

  • Roy Beck, MD, P.D., Founder and Executive Director, T1D Exchange Clinic Coordinating Center

10:50 – 11:30 am: How Access Accelerates Scientific Advancement – The T1D Exchange Biobank

This session will illustrate how increased access to well-annotated, high quality biospecimens has accelerated scientific advancements that will directly address the unmet medical needs of the type 1 population

  • Wendy Wolf, PhD, Director, Collaborative Science, T1D Exchange
  • Peter Robinson, PhD, CSO and Co-Founder, Enable Biosciences

11:30 – 12:00 pm: Quality Improvement 101

An overview of how T1D Exchange’s Quality Improvement initiative that can be utilized to learn valuable patient-driven health outcomes from real world clinical settings


  • Nicole Rioles, Director of Quality Improvement, T1D Exchange


  • Shideh Majidi, Assistant Professor, Pediatric Endocrinology, Barbara Davis Center (BDC) for Diabetes, University of Colorado
  • Sanjeev Mehta, Director of Quality, Joslin Diabetes Center and Instructor of Pediatrics, Harvard Medical School

12:00 – 12:50 pm: Networking Luncheon

1:00 – 1:45 pm: Keynote Address

Stemming from his long career in government, industry and nonprofits focused on accelerating medical solutions, Mr. Simon will offer his reflections on the future of medical innovation as he challenges you to accelerate innovation in diabetes.

  • Greg Simon, Director, Biden Cancer Initiative

1:45 – 2:20 pm: The Diabetes Innovation Challenge

An exciting discussion about the breakthrough success of the 2016 Diabetes Innovation Challenge, illustrating T1D Exchange’s role in identifying and supporting entrepreneurs and innovative solutions to fill gaps in care and treatments for the broader population of people with diabetes. There also will be a preview of the 2018 Diabetes Innovation Challenge

  • George Serbedzija, PhD, Chief Business Officer, T1D Exchange
  • Brent Buchine, PhD, Co-Founder and CTO, Windgap Medical, Inc.

2:30 – 3:30 pm: Cocktail Reception (Grand Ballroom Foyer)

October 3rd, 2017
7:30 a.m. – 3:00 p.m., followed by a networking reception
Royal Sonesta, Boston